免責聲明: 本站彙整 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公開資料,僅供一般參考,不構成醫療建議、診斷、治療建議或投資建議。

FDA 510(k)

貝美治療系統Evo

K 號:K231368 · 2023-06-09

申請人Bemer Int AG
決定日期2023-06-09
產品代碼NGX
諮詢委員會PM
決定相當於

器材摘要

Bemer Therapy System Evo is the device name listed in this FDA 510(k) record. The listed applicant is Bemer Int AG. It received FDA 510(k) clearance on 2023-06-09 under 510(k) number K231368. The device is classified under product code NGX. It was reviewed by the PM advisory panel. FDA Decision: Substantially Equivalent.

常見問題

What is the Bemer Therapy System Evo?

Bemer Therapy System Evo is a medical device that received FDA 510(k) clearance on 2023-06-09. The listed applicant is Bemer Int AG. The 510(k) number is K231368.

When did Bemer Therapy System Evo receive FDA 510(k) clearance?

Bemer Therapy System Evo received FDA 510(k) clearance on 2023-06-09, under 510(k) number K231368.

Who is the listed applicant for Bemer Therapy System Evo?

The FDA 510(k) record lists Bemer Int AG as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Bemer Therapy System Evo?

The FDA product code for Bemer Therapy System Evo is NGX.

相關臨床試驗

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

其他以 Bemer Int AG 為申請人之記錄

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

相關器械(代碼:NGX)

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

官方來源

在 FDA 資料庫中查看 →

資料來源為 FDA Open API。如需最新且權威的資訊,請始終參閱官方記錄。

↑